(864) 370-3297 info@glytecsystems.com

About
Solutions
Resources
Case Studies
Blog
Request a Demo

Evidence

The safety and efficacy of Glytec’s solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences around the globe. We invite you to explore them here.

Filter by Topic

Hypoglycemia Reduction Inpatient Glycemic Management SubQ Insulin IV Insulin Length of Stay Reduction Diabetic Ketoacidosis (DKA) Resolution A1C Reduction Basal Bolus Adoption Cardiovascular Patients Cost of Care Reduction Hyperglycemia Reduction Staff Education Surgical Patients Academic Medical Center Connected Diabetes Technologies ICU Outpatient Glycemic Management Readmissions Reduction Research Study Virtual Care Clinical Surveillance POC Testing Time Savings Transition IV to SubQ Competitive Comparison Continuous Glucose Monitoring Emergency Department Glucommander™ H2H® (Hospital to Home) Heart Failure Patients Patients Without Diabetes

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

High-dose insulin infusion in patients with COVID-19

Read More

Clinical Outcomes Of Euglycemic Diabetic Ketoacidosis (euDKA) Treated With a Computerized Insulin Algorithm: Descriptive Analysis of a Nationwide Cohort

Read More

Hypoglycemia Treatment in the Hospital: The 15/15 Rule is Over

Read More

Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia

Read More

The Power of Inpatient Glucometrics

Read More

Glycemic Outcomes for Adult Type 1 Diabetes (T1D) With and Without DKA

Read More

IV Insulin via Glucommander, eGlycemic Management System (eGMS), Demonstrates Low Rates of Hypoglycemia in Patients with Low eGFR Compared to Other Electronic Glycemic Management Tools

Read More

Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19

Read More

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept

Read More

Use of Technology Reduces Incidence of Hypoglycemia- Related Adverse Drug Events Among Patients Requiring Insulin Therapy While Hospitalized

Read More

Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing

Read More

Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG?

Read More

Use of a Computer-Based Insulin Infusion Algorithm to Treat Diabetic Ketoacidosis in the Emergency Department

Read More

Use of the eGlycemic Management Solution by Glytec to Identify, Treat and Improve Glycemic Care for CHF Patients

Read More

Comparative Effectiveness of a Computerized Algorithm Versus a Physician Instituted Protocol to Manage Insulin Infusions After Cardiac Surgery

Read More

Glytec eGlycemic Management System in Combination With Clinical Surveillance Reduces Hypoglycemia and Can Identify Patients at Risk of Increased Length of Stay in Hospitalized Patients With Diabetic K

Read More

Perioperative Use of the Glucommander for Glucose Control in Patients Undergoing Cardiac Surgery

Read More

Use of the Glucommander for Glycemic Control in Cardiac Surgery Patients

Read More

Subscribe to our blog

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.

Terms of Use
Legal Disclaimer
Privacy Policy
Contraindications, Warnings and Precautions

© 2023 Glytec, LLC on behalf of Aseko, Inc.

The eGlycemic Management System^® is a modularized solution for glycemic management across the care continuum that includes Glucommander^™. Glucommander^™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander^™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.

Glucommander^™ is only available for use in the United States.

This site is only intended for use in the United States.

Aseko is a registered trademark of Aseko, Inc.